Biomedical data might hold the key to finding the cure for currently incurable diseases. Our mission is to reduce the complexity of RNA-seq data into plausible candidates for drug and biomarker development. Our Software as a service (SaaS) to extract biologically relevant RNA isoforms from raw RNA-seq data. Discover new drug targets and biomarkers through splice isoform quantification coupled with predictive-analytics. Prioritize disease-related genes connecting your data to our databases and algorithms. Rapidly advance to experimental validation with a well supported list of targets.
Company Growth (employees)
Huntington, US
Size (employees)
7 (est)
Envisagenics was founded in 2014 and is headquartered in Huntington, US

Envisagenics Office Locations

Envisagenics has an office in Huntington

Envisagenics Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$225 k

Latest funding size

$225 k

Time since last funding

about 2 years


Envisagenics's latest funding round in August 2015 was reported to be $225 k. In total, Envisagenics has raised $225 k

Traffic Overview of Envisagenics

Envisagenics Online and Social Media Presence

Envisagenics Company Life and Culture

You may also be interested in